Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Regulatory News (SIHL)

Share Price Information for Symphony (SIHL)

Share Price is delayed by 15 minutes
Get Live Data
0.348    0.00 (0.00%)
Bid:
0.324
Ask:
0.37
Spread: 0.046 (14.198%)
Market Cap: $178.65m
SIHL Live PriceLast checked at - London Stock Exchange

Intraday Symphony Share Chart

Key Information Document

22 Apr 2020 07:00

RNS Number : 3948K
Symphony International Holdings Ltd
22 April 2020
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

Symphony International Holdings Limited ("Symphony")

 

22 April 2020

 

Key Information Document

 

Symphony International Holdings Limited ("Symphony" or the "Company") (LSE: SIHL) announces that an updated Key Information Document is available on its website, www.symphonyasia.com.

 

 

For further information:

Symphony Asia Holdings Pte. Ltd. +65 6536 6177

 

Anil Thadani 

Rajgopal Rajkumar

 

Dealing codes

 

The ISIN number of the Ordinary Shares is VGG548121059, the SEDOL code is B231M63 and the TIDM is SIHL.

 

The LEI number of the Company is 254900MQE84GV5DS6F03.

 

About Symphony

Symphony International Holdings Limited (LSE:SIHL) is a London listed strategic investment company that invests in consumer related businesses, primarily in the healthcare, hospitality, lifestyle (including branded real estate developments), logistics and education sectors predominantly in Asia. It offers a way for investors to gain exposure to rising disposable incomes and wealth in fast growing economies. Symphony's objective is to provide superior capital growth by investing in high quality companies and form long-term business partnerships with talented entrepreneurs and management teams. Symphony's investment team has a broad range of expertise - many of its professionals have been working in Asia for more than 30 years. For more information please visit our website at www.symphonyasia.com. 

 

No representation or warranty is made by the Company as to the accuracy or completeness of the information contained in this announcement and no liability will be accepted for any loss arising from its use.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Company in any jurisdiction. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decisions.

 

This announcement is not an offer of securities for sale into the United States. The Company's securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

The Company and the Investment Manager are not associated or affiliated with any other fund managers whose names include "Symphony", including, without limitation, Symphony Financial Partners Co., Ltd.

 

End of Announcement

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCKKDBBQBKDAQB
Date   Source Headline
28th Apr 20232:58 pmRNSPerformance Update
6th Apr 20237:00 amRNSNotice of Annual General Meeting
6th Apr 20237:00 amRNSAnnual Financial Report
23rd Mar 20237:00 amRNSNet Asset Value(s)
23rd Mar 20237:00 amRNSShareholder Update
23rd Mar 20237:00 amRNSPreliminary Results
18th Jan 20237:00 amRNSInvestment in MAVI Holding Pte. Ltd. ("MAVI")
20th Dec 20227:00 amRNSNet Asset Value(s)
20th Dec 20227:00 amRNSShareholder Update
23rd Sep 20227:00 amRNSKey Information Document
14th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 202211:25 amRNSDirector/PDMR Shareholding
9th Sep 202210:41 amRNSDirector/PDMR Shareholding
6th Sep 202210:11 amRNSDirector/PDMR Shareholding
1st Sep 20227:00 amRNSNet Asset Value(s)
1st Sep 20227:00 amRNSInterim Financial Results
1st Sep 20227:00 amRNSShareholder Update
22nd Jun 202211:39 amRNSDirector/PDMR Shareholding
21st Jun 202211:52 amRNSDirector/PDMR Shareholding
20th Jun 202211:12 amRNSDirector/PDMR Shareholding
10th Jun 20229:17 amRNSDirector/PDMR Shareholding
9th Jun 20229:10 amRNSDirector/PDMR Shareholding
7th Jun 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSShareholder Update
5th May 202211:13 amRNSDirector/PDMR Shareholding
3rd May 202210:39 amRNSDirector/PDMR Shareholding
28th Apr 20229:57 amRNSDirector/PDMR Shareholding
25th Apr 20229:48 amRNSPerformance Update
25th Apr 20229:32 amRNSResult of AGM
19th Apr 202210:54 amRNSDirector/PDMR Shareholding
6th Apr 202210:47 amRNSDirector/PDMR Shareholding
4th Apr 202211:46 amRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSNotice of Annual General Meeting
4th Apr 20227:00 amRNSAnnual Financial Report
25th Mar 202210:21 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSNet Asset Value(s)
18th Mar 20227:00 amRNSShareholder Update
18th Mar 20227:00 amRNSPreliminary Results
28th Jan 202210:22 amRNSDirector/PDMR Shareholding
24th Jan 20229:55 amRNSDirector/PDMR Shareholding
21st Jan 20221:51 pmRNSDirector/PDMR Shareholding
18th Jan 202210:46 amRNSDirector/PDMR Shareholding
13th Jan 20229:43 amRNSDirector/PDMR Shareholding
10th Jan 202210:11 amRNSDirector/PDMR Shareholding
24th Dec 202110:15 amRNSDirector/PDMR Shareholding
3rd Dec 20219:56 amRNSDirector/PDMR Shareholding
26th Nov 20217:00 amRNSNet Asset Value(s)
26th Nov 20217:00 amRNSShareholder Update
28th Oct 202110:37 amRNSDirector/PDMR Shareholding
28th Oct 202110:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.